Cargando…
Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function
High levels of the anti-apoptotic BCL-2 family member MCL-1 are frequently found in breast cancer and, appropriately, BH3-mimetic drugs that specifically target MCL-1’s function in apoptosis are in development as anti-cancer therapy. MCL-1 also has reported non-canonical roles that may be relevant i...
Autores principales: | Campbell, Kirsteen J., Mason, Susan M., Winder, Matthew L., Willemsen, Rosalie B. E., Cloix, Catherine, Lawson, Hannah, Rooney, Nicholas, Dhayade, Sandeep, Sims, Andrew H., Blyth, Karen, Tait, Stephen W. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408186/ https://www.ncbi.nlm.nih.gov/pubmed/33785871 http://dx.doi.org/10.1038/s41418-021-00773-4 |
Ejemplares similares
-
MCL-1 is a prognostic indicator and drug target in breast cancer
por: Campbell, Kirsteen J., et al.
Publicado: (2018) -
MCL-1 is a clinically targetable vulnerability in breast cancer
por: Winder, Matthew L, et al.
Publicado: (2022) -
Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death
por: Bock, Florian J., et al.
Publicado: (2021) -
Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics
por: Koessinger, Anna L., et al.
Publicado: (2022) -
Allosteric Inhibition of Anti-Apoptotic MCL-1
por: Lee, Susan, et al.
Publicado: (2016)